Parameters (Units) | Values | Source and comments | |
---|---|---|---|
ROF | ROF N-oxide | ||
MW(g·mol−1) | 403.21 | 419.21 | Chemspider |
pKa (Base) | 13.3 (acid); 2.4 (base) | 12.92, 0.65 | [9], Optimized for ROF N-oxide |
LogP | 3.5 | 2.6 | Optimized |
Solubility (μg·mL−1) | 0.5 (@pH7.4) | - | [9] |
Papp (X 10–5 cm⋅s−1) | 0.01 | - | [20] |
fup | 0.011 | 0.034 | [9] |
Rbp | 0.73 | 0.62 | Calculated by PK-Sim |
CYP3A4 CLint,u (μL/min/mg)a | 0.90/0.55 | 0.010/0.0093 | Optimized based on the observed human PK |
CYP1A2 CLint,u (μL/min/mg)a | 0.55/0.33 | - | Calculated based on lower clearance in COPD patients |
CLa (μL/min/mg)a | - | 0.10/0.093 | |
CLR(L/h) | GFR*fup | Default | |
GFR fraction | 1.0 | Default | |
KIns,p scale | 5.0 | - | Optimized based on the observed human PK |
Partition coefficients | Rodgers and Rowland | Optimized based on the observed human PK | |
Cellular permeabilities | PK-Sim Standard | ||
Concentration (μM/L liver tissue) | |||
CYP3A4 | 4.32 | Default | |
CYP1A2 | 1.80 | ||
Abundance in HLM (pmol/mg protein) | |||
CYP3A4 | 137 | [21] | |
CYP1A2 | 52 | ||
kdeg | |||
CYP3A4 | 0.019 h−1(liver),0.03 h−1 (intestine) | [22] | |
CYP1A2 | 0.017 h−1(liver), 0.03 h−1 (intestine) | ||
Ki CYP3A4 (μM) | 2.79 | - | [9] |